Bioduro

Armin Spura, PhD, CEO of BioDuro, discusses what sets the company apart as a CRDMO

BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation

Armin Spura, PhD, CEO of BioDuro, talks about the company’s evolution into a fully integrated contract, research, and development manufacturing organization (CRDMO), offering seamless services across discovery to development and commercialization. Spura discusses recent expansions in commercial-scale API production, peptide scale-up, and high-potency capabilities at the company’s Bengbu, China location. 

What differentiates BioDuro as a high-touch, high-quality CRDMO and how its integrated model streamlines drug development.

The company’s recent facility expansions in the U.S. and China in drug substance synthesis, peptide production, and more.

How BioDuro navigates geopolitical and regulatory landscapes while scaling global operations and client-specific solutions.

Videos

How BioDuro is expanding its global CRDMO footprint by improving integrated capabilities and delivering high-quality, end-to-end solutions for drug development and manufacturing

Learn how to extend product life cycles through innovative reformulation strategies that enhance patient compliance and streamline late-phase manufacturing. Join BioDuro-Sundia's webinar to explore opportunities to boost product performance.

https://www.pharmtech.com/pt_w/commercial-excellence

Join BioDuro-Sundia’s exclusive webinar to discover cutting-edge technologies for extending product life cycles through innovative reformulation strategies. Learn from real-world case studies how to streamline late-phase drug product development and manufacturing and unlock new market opportunities with enhanced patient compliance. Gain actionable insights to overcome obstacles in late-phase development and manufacturing, such as scaling up production, ensuring regulatory compliance, and managing complex supply chains, and accelerate your product’s path to success. Don’t miss this chance to stay ahead in the competitive pharmaceutical landscape.

Learn strategies for transforming products to enhance release profiles.

Practice techniques to boost patient compliance through optimized dosing strategies.

Implement effective life cycle management strategies for late-phase manufacturing

Executive vice presidents of product development


Vice President of Product Development and Manufacturing
BioDuro-Sundia

, is a pharmaceutical scientist with over 21 years of experience in formulation and process development for solid oral dosages targeting oncology, inflammation, gastrointestinal, and CNS indications. Mittal has worked with industry leaders such as BioDuro-Sundia, AbbVie, and Takeda, and is the author of 3 books and 4 US patents. His expertise includes product development strategy, project management, regulatory interactions, and quality by design implementation. He is dedicated to advancing drug development and enhancing industry practices.

Webcasts

Webinar Date/Time: Tue, Dec 3, 2024 11:00 AM EST


Bioduro

Articles